Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected finnish breast cancer patients

Journal of the National Cancer Institute

Volumn 92, Issue 18, 2000, Pages 1529-1531

  Syrjäkoski, Kirsi ^a   Vahteristo, Pia ^b   Eerola, Hannaleena ^c   Tamminen, Anitta ^b   Kivinummi, Kati ^a   Sarantaus, Laura ^b   Holli, Kaija ^d   Blomqvist, Carl ^c,e   Kallioniemi, Olli P ^a   Kainu, Tommi ^a   Nevanlinna, Heli ^b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c Helsinki University Central Hospital   (Sweden)

^d Tampere University Hospital   (Sweden)

^e UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; COST EFFECTIVENESS ANALYSIS; DNA POLYMORPHISM; FAMILY HISTORY; FEMALE; FINLAND; GENE MUTATION; GENE SEQUENCE; GENETIC COUNSELING; GENETIC SCREENING; HUMAN; MAJOR CLINICAL STUDY; MUTATION RATE; OVARY CANCER; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0034692434     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/92.18.1529     Document Type: Article

References (22)

1. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
2. Identification of the breast cancer susceptibility gene BRCA2
3. Germ-line BRCA1 mutations in women with sporadic breast cancer: Clinical correlations
4. Frequency of breast cancer attributable to BRCA1 in a population-based series of American women
5. Prevalence of mutations in the BRCAI gene among Chinese patients with breast cancer
6. A single BRCA2 mutation in male breast and female breast cancer families from Iceland with varied cancer phenotypes
7. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2
8. A low proportion of BRCA2 mutations in Finnish breast cancer families
9. Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: Evidence for additional susceptibility genes
10. Evidence for founder mutations in Finnish BRCA1 and BRCA2 families
11. Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland
12. High prevalence of the 999del5 mutation in Icelandic breast cancer patients
13. Study of a single BRCA2 mutation with high carrier frequency in a small population
14. Population-based study of risk of breast cancer in carriers of BRCA2 mutation
15. Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer
16. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer
17. Recommendations for medical management of hereditary breast and ovarian cancer: The French National Ad Hoc Committee
18. Statement of the American Society of Clinical Oncology: Genetic testing for cancer susceptibility, Adopted on February 20, 1996
19. BRCA1 sequence analysis in women with high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing
20. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer